NTRA Natera, Inc. · NASDAQ · Services-Medical Laboratories

What each lens says: insiders — insiders bought $0.0M and sold $63.2M in 30 days (0 buys, 58 sales) · funds — D. E. Shaw, Viking Global opened or grew

no price series yet

What the readers say — 0 reads of posts over 50 upvotes, last 30 days

no reads yet — the model key is not set on the server

posts per day (height) and word-score mood (color), gated

Connected to NTRA — asked of the layer, served live

funds.holdings

references ×3 13f:0000919574-26-003501:632307104
references ×3 13f:0000919574-26-005478:632307104
references ×1 13f:0001103804-26-000006:632307104
references ×2 13f:0001104659-26-059240:632307104
references ×1 13f:0001104659-26-096910:632307104
references ×1 13f:0001104659-26-097217:632307104
references ×2 13f:0001536411-26-000004:632307104
references ×1 13f:0001536411-26-000006:632307104

funds.securities

references ×1 NATERA INC

insiders.trades

references ×1 EXECUTIVE CHAIRMAN
references ×1 EXECUTIVE CHAIRMAN
references ×1 EXECUTIVE CHAIRMAN
references ×1 EXECUTIVE CHAIRMAN
references ×1 EXECUTIVE CHAIRMAN
references ×1 EXECUTIVE CHAIRMAN
references ×1 EXECUTIVE CHAIRMAN
references ×1 EXECUTIVE CHAIRMAN
references ×1 EXECUTIVE CHAIRMAN
references ×1 EXECUTIVE CHAIRMAN
references ×1 EXECUTIVE CHAIRMAN
references ×1 EXECUTIVE CHAIRMAN

research.hypotheses

discusses ×1 hyp:basket:06f0c2675ba4:20260907
discusses ×1 hyp:basket:1186c0f803c4:20260907
discusses ×1 hyp:basket:7a5625026fab:20260907
discusses ×1 hyp:basket:821db5a40738:20260907
discusses ×1 hyp:basket:954716bd75f5:20260907
discusses ×1 hyp:basket:d63b111fce31:20260907
discusses ×1 hyp:cluster:02d69ca95237:20260907
discusses ×1 hyp:cluster:4470115648ab:20260907
discusses ×1 hyp:cluster:72afa5c05f64:20260907
discusses ×1 hyp:cluster:7affb52b380f:20260907
discusses ×1 hyp:cluster:a8cefee12e39:20260907
discusses ×1 hyp:cluster:b5521bef9e81:20260907

open the relational graph ↗

History of NTRA — the layer's log: every relationship that appeared, strengthened or faded

2026-10-03 01:43 appeared references form4:0002010019-26-000030:2 insiders.trades · crossed the bar · ×1
2026-10-03 01:43 appeared references form4:0002010019-26-000030:1 insiders.trades · crossed the bar · ×1
2026-10-03 01:43 appeared references form4:0002010019-26-000030:0 insiders.trades · crossed the bar · ×1
2026-10-03 01:43 appeared references form4:0001711968-26-000023:0 insiders.trades · crossed the bar · ×1
2026-09-28 01:54 strengthened references 13f:0001104659-26-059240:632307104 funds.holdings · ×2
2026-09-26 20:31 strengthened references 13f:0001536411-26-000004:632307104 funds.holdings · ×2
2026-09-26 02:24 appeared references form4:0001646649-26-000033:11 insiders.trades · crossed the bar · ×1
2026-09-26 02:24 appeared references form4:0001646649-26-000033:10 insiders.trades · crossed the bar · ×1
2026-09-26 02:24 appeared references form4:0001646649-26-000033:9 insiders.trades · crossed the bar · ×1
2026-09-26 02:24 appeared references form4:0001646649-26-000033:8 insiders.trades · crossed the bar · ×1
2026-09-26 02:24 appeared references form4:0001646649-26-000033:7 insiders.trades · crossed the bar · ×1
2026-09-26 02:24 appeared references form4:0001646649-26-000033:6 insiders.trades · crossed the bar · ×1
2026-09-26 02:24 appeared references form4:0001646649-26-000033:5 insiders.trades · crossed the bar · ×1
2026-09-26 02:24 appeared references form4:0001646649-26-000033:4 insiders.trades · crossed the bar · ×1
2026-09-26 02:23 appeared references form4:0001646649-26-000033:3 insiders.trades · crossed the bar · ×1
2026-09-26 02:23 appeared references form4:0001646649-26-000033:2 insiders.trades · crossed the bar · ×1
2026-09-26 02:23 strengthened references form4:0001646649-26-000033:1 insiders.trades · ×8
2026-09-26 02:23 strengthened references form4:0001646649-26-000033:1 insiders.trades · ×4
2026-09-26 02:23 strengthened references form4:0001646649-26-000033:1 insiders.trades · ×2
2026-09-26 02:23 appeared references form4:0001646649-26-000033:1 insiders.trades · crossed the bar · ×1
2026-09-26 02:15 appeared references form4:0001646649-26-000033:0 insiders.trades · crossed the bar · ×1
2026-09-22 23:15 strengthened references news:d7821fcd04be34e6 news.articles · ×8
2026-09-22 23:15 strengthened references news:fb52e9e586d13ecd news.articles · ×4
2026-09-22 23:15 strengthened references news:046d8c60a187f3ab news.articles · ×4
2026-09-22 23:15 strengthened references news:1b885bee80ee224a news.articles · ×4
2026-09-22 23:15 strengthened references news:d72b15a5b067974e news.articles · ×8
2026-09-22 23:15 strengthened references news:9829fc2b768249c0 news.articles · ×4
2026-09-22 23:15 appeared references news:3dbf33e3c09b19db news.articles · crossed the bar · ×1
2026-09-22 23:15 appeared references news:5a40b823e28965a3 news.articles · crossed the bar · ×1
2026-09-22 23:15 appeared references news:9e8be4f07497fe3e news.articles · crossed the bar · ×1
2026-09-22 23:15 appeared references news:15743d9c40dd7f7f news.articles · crossed the bar · ×1

The reads — each post's actual stance, by a language model

no reads yet for this ticker

Reddit posts — over 50 upvotes

post	⬆	flair	word score
no gated posts yet

The comments — loudest in 30 days, over 10 upvotes

no loud comments naming this ticker yet

News

seen	headline	source
2026-09-22T13:56	Natera Inc stock reaches all-time high at 373.58 USD	Investing.com
2026-09-22T12:00	A cancer test receives its second Japan approval in three months to guide bladder-cancer treatment.	Stock Titan
2026-09-21T09:08	Natera, Inc. (NTRA) Stock Analysis: Amidst Rapid Growth, What Lies Ahead for This Diagnostics Leader?	DirectorsTalk Interviews
2026-09-20T19:22	Natera stock gains as new lung cancer study supports Signatera value	AD HOC NEWS
2026-09-18T10:00	A positive result after lung cancer surgery was linked to about 5 times the risk of recurrence	Stock Titan
2026-09-18T01:45	Natera (NASDAQ: NTRA) co-founder sells 9,150 shares under 10b5-1 plan	Stock Titan
2026-09-17T21:32	Natera Inc (NTRA) Stock Up 6.1% but GF Value Says Overvalued -- GF Score: 77/100	GuruFocus
2026-09-17T19:15	Natera Inc Stock (NTRA) Moved Up by 5.05% on Sep 17: Key Drivers Unveiled	TradingKey
2026-09-17T03:18	Natera executive chairman Matthew Rabinowitz sells $34.8m in stock By Investing.com	Investing.com Canada
2026-09-17T01:41	Natera (NASDAQ: NTRA) chair unloads stock in preset plan	Stock Titan
2026-09-15T20:54	Trust tied to Natera (NASDAQ: NTRA) eyes new stock sale after multimillion-dollar trades	Stock Titan
2026-09-15T13:59	Natera stock hits all-time high at 343.94 USD By Investing.com	Investing.com Nigeria
2026-09-14T09:13	Natera, Inc. (NTRA) Stock Analysis: A $47 Billion Market Cap Powerhouse with a Robust Growth Trajectory	DirectorsTalk Interviews
2026-09-12T03:20	Natera executive chairman Matthew Rabinowitz sells $16.4m in shares By Investing.com	Investing.com South Africa
2026-09-12T01:51	Executive chair of Natera (NTRA) sells 50,000 shares	Stock Titan
2026-09-11T20:29	Insider at Natera (NTRA) plans stock sale, with size detailed in new SEC notice	Stock Titan
2026-09-09T07:00	Jim Cramer Calls Natera (NTRA) “a Promising Story”	Yahoo Finance
2026-09-08T08:44	Rothschild Redburn initiates Natera stock with buy on MRD leadership By Investing.com	Investing.com Canada
2026-09-08T08:18	Rothschild Redburn initiates Natera stock with buy on MRD leadership	Investing.com
2026-09-07T07:00	Natera, Inc. (NTRA) Stock Analysis: A $47.31 Billion Healthcare Innovator with Strong Buy Ratings	DirectorsTalk Interviews

Who holds it — the big funds' 13F reports, each manager's newest quarter

manager	position	shares	move vs prior quarter	as of
D. E. Shaw	$322M	1,186,577	new	2026-06-30
ARK Invest	$186M	688,855	held	2026-06-30
Coatue	$149M	549,954	held	2026-06-30
Viking Global	$106M	390,694	new	2026-06-30
Duquesne (Druckenmiller)	$0M	3,186,306	held	2026-06-30

Insider trades — Form 4 open-market buys and sales

traded	filed	who	side	shares	price	value
2026-10-01	2026-10-02	Chapman Steven Leonard CEO AND PRESIDENT	sell	1,273	$413.31	$526,144
2026-10-01	2026-10-02	Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS	sell	200	$411.62	$82,324
2026-10-01	2026-10-02	Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS	sell	954	$413.11	$394,104
2026-10-01	2026-10-02	Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS	sell	1,846	$415.07	$766,218
2026-09-23	2026-09-25	Sheena Jonathan other	sell	400	$385.10	$154,041
2026-09-23	2026-09-25	Sheena Jonathan other	sell	2,175	$386.71	$841,104
2026-09-23	2026-09-25	Sheena Jonathan other	sell	2,734	$387.65	$1,059,847
2026-09-23	2026-09-25	Sheena Jonathan other	sell	1,293	$388.71	$502,598
2026-09-23	2026-09-25	Sheena Jonathan other	sell	2,320	$389.69	$904,069
2026-09-23	2026-09-25	Sheena Jonathan other	sell	110	$390.42	$42,946
2026-09-23	2026-09-25	Sheena Jonathan other	sell	390	$385.29	$150,263
2026-09-23	2026-09-25	Sheena Jonathan other	sell	2,300	$386.64	$889,271
2026-09-23	2026-09-25	Sheena Jonathan other	sell	2,846	$387.74	$1,103,494
2026-09-23	2026-09-25	Sheena Jonathan other	sell	1,341	$388.76	$521,332
2026-09-23	2026-09-25	Sheena Jonathan other	sell	1,935	$389.71	$754,090
2026-09-23	2026-09-25	Sheena Jonathan other	sell	220	$390.52	$85,916
2026-09-16	2026-09-17	Sheena Jonathan other	sell	200	$348.02	$69,605
2026-09-16	2026-09-17	Sheena Jonathan other	sell	100	$349.05	$34,904
2026-09-16	2026-09-17	Sheena Jonathan other	sell	1,400	$353.83	$495,362
2026-09-16	2026-09-17	Sheena Jonathan other	sell	450	$354.91	$159,711
2026-09-16	2026-09-17	Sheena Jonathan other	sell	800	$355.95	$284,758
2026-09-16	2026-09-17	Sheena Jonathan other	sell	200	$356.87	$71,373
2026-09-15	2026-09-16	Rabinowitz Matthew EXECUTIVE CHAIRMAN	sell	1,481	$339.24	$502,407
2026-09-15	2026-09-16	Rabinowitz Matthew EXECUTIVE CHAIRMAN	sell	2,549	$340.25	$867,293
2026-09-15	2026-09-16	Rabinowitz Matthew EXECUTIVE CHAIRMAN	sell	1,813	$341.41	$618,970
2026-09-15	2026-09-16	Rabinowitz Matthew EXECUTIVE CHAIRMAN	sell	1,956	$342.18	$669,305
2026-09-15	2026-09-16	Rabinowitz Matthew EXECUTIVE CHAIRMAN	sell	2,240	$343.56	$769,583
2026-09-15	2026-09-16	Rabinowitz Matthew EXECUTIVE CHAIRMAN	sell	5,839	$344.49	$2,011,453
2026-09-15	2026-09-16	Rabinowitz Matthew EXECUTIVE CHAIRMAN	sell	2,700	$345.38	$932,525
2026-09-15	2026-09-16	Rabinowitz Matthew EXECUTIVE CHAIRMAN	sell	1,122	$346.68	$388,969

Congressional trades — House periodic transaction reports

traded	filed	member	type	owner	amount
no filings naming this ticker in the window